Header Logo

Connection

ANANTH ANNAPRAGADA to Magnetic Resonance Imaging

Back to Details
This is a "connection" page, showing publications ANANTH ANNAPRAGADA has written about Magnetic Resonance Imaging.
ANANTH ANNAPRAGADA
Connection Strength
2.277
Magnetic Resonance Imaging
  1. Ferumoxytol-enhanced MRI of retroplacental clear space disruption in placenta accreta spectrum. Placenta. 2025 Feb; 160:100-106.
    View in: PubMed
    Score: 0.419
  2. Pre-clinical magnetic resonance imaging of retroplacental clear space throughout gestation. Placenta. 2019 02; 77:1-7.
    View in: PubMed
    Score: 0.278
  3. A Hyperfluorinated Hydrophilic Molecule for Aqueous 19F MRI Contrast Media. Contrast Media Mol Imaging. 2018; 2018:1693513.
    View in: PubMed
    Score: 0.274
  4. Magnetic Resonance Imaging of Atherosclerotic Plaque at Clinically Relevant Field Strengths (1T) by Targeting the Integrin a4?1. Sci Rep. 2018 02 27; 8(1):3733.
    View in: PubMed
    Score: 0.261
  5. Pre-clinical evaluation of a nanoparticle-based blood-pool contrast agent for MR imaging of the placenta. Placenta. 2017 Sep; 57:60-70.
    View in: PubMed
    Score: 0.249
  6. A Novel Liposomal Nanoparticle for the Imaging of Amyloid Plaque by Magnetic Resonance Imaging. J Alzheimers Dis. 2016; 52(2):731-45.
    View in: PubMed
    Score: 0.225
  7. New dual mode gadolinium nanoparticle contrast agent for magnetic resonance imaging. PLoS One. 2009 Oct 29; 4(10):e7628.
    View in: PubMed
    Score: 0.146
  8. A surrogate marker for very early-stage tau pathology is detectable by molecular magnetic resonance imaging. Theranostics. 2022; 12(12):5504-5521.
    View in: PubMed
    Score: 0.088
  9. Nanoprobes for Computed Tomography and Magnetic Resonance Imaging in Atherosclerosis Research. Methods Mol Biol. 2022; 2419:809-823.
    View in: PubMed
    Score: 0.085
  10. Pre-clinical dose-ranging efficacy, pharmacokinetics, tissue biodistribution, and toxicity of a targeted contrast agent for MRI of amyloid deposition in Alzheimer's disease. Sci Rep. 2020 09 30; 10(1):16185.
    View in: PubMed
    Score: 0.078
  11. Multimodal Magnetic Resonance and Near-Infrared-Fluorescent Imaging of Intraperitoneal Ovarian Cancer Using a Dual-Mode-Dual-Gadolinium Liposomal Contrast Agent. Sci Rep. 2016 12 22; 6:38991.
    View in: PubMed
    Score: 0.060
  12. T1 relaxivity of core-encapsulated gadolinium liposomal contrast agents--effect of liposome size and internal gadolinium concentration. Acad Radiol. 2008 Oct; 15(10):1259-63.
    View in: PubMed
    Score: 0.034
  13. Advances in nanoprobes for molecular MRI of Alzheimer's disease. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2024 Mar-Apr; 16(2):e1946.
    View in: PubMed
    Score: 0.025
  14. Nanoparticle Contrast-enhanced MRI for Visualization of Retroplacental Clear Space Disruption in a Mouse Model of Placental Accreta Spectrum (PAS). Acad Radiol. 2023 Jul; 30(7):1384-1391.
    View in: PubMed
    Score: 0.022
  15. Nanoparticle Contrast-enhanced T1-Mapping Enables Estimation of Placental Fractional Blood Volume in a Pregnant Mouse Model. Sci Rep. 2019 12 10; 9(1):18707.
    View in: PubMed
    Score: 0.018
  16. Neuroimaging in Alzheimer's disease: preclinical challenges toward clinical efficacy. Transl Res. 2016 09; 175:37-53.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.